Longitudinal changes of gait parameters in early Parkinson’s disease
Objective: To analyse changes in quantitative gait parameters in patients with very early, unilateral, PD over 12 months follow-up. Background: Parkinson’s disease (PD) is frequently characterized by progressive gait…Prevalence of neurogenic orthostatic hypotension in the idiopathic Parkinson Progression Marker Initiative cohort.
Objective: To assess prevalence of neurogenic and peripheral orthostatic hypotension (nOH/pOH) in the PPMI (https://www.ppmi-info.org) idiopathic Parkinson disease (PD) cohort and to examine whether nOH,…Is dopamine replacement therapy an addictive drug?
Objective: To identify common clinical and imaging abnormalities in Parkinson's disease patients and heroin-dependent patients compared with healthy controls in order to better understand the pathophysiology…Data-driven prediction of fatigue in Parkinson’s disease patients
Objective: The overall aim of this study is to identify which items of the Fatigue Severity Scale (FSS) best predict clinically significant fatigue in male…Dopamine dysregulation syndrome in Parkinson’s disease after COVID-19. Case report.
Objective: To describe a case of a man with Parkinson’s disease (PD), who was developed dopamine dysregulation syndrome (DDS) after COVID-19. Background: Parkinson’s disease is…The effect of deep brain stimulation on impulse control related disorders in Parkinson’s disease – a retrospective review of 137 patients
Objective: To assess the effect of deep brain stimulation on impulse control related disorders on patients with Parkinson’s Disease (PD) at our centre. Background: Approximately…Conception of a sensor- and home-based measurement of camptocormia
Objective: This conception aims to outline the medical and technical requirements and a possible setup for an inertial-measurement-unit (IMU) quantifying camptocormia over a longer period…Comparative score on the MDS-UPDRS scale I, II and IV in patients with Parkinson disease with and without cardiovascular risk factors.
Objective: To find any relationship between cardiovascular risk factors such as diabetes mellitus, hypertension or both and worse state in patient with PD measured with…Soluble urokinase-type plasminogen activator receptor (SuPAR) in patients with Parkinson’s disease
Objective: The objective of this study was to assess if soluble urokinase-type plasminogen activator receptor (SuPAR) is elevated in patients with Parkinson's disease (PD). Background:…Belly Dancer’s Dyskinesia with Systemic Lupus Erythematosus: A Case Report
Objective: To present a rare case of belly dancer’s dyskinesia with systemic lupus erythematosus (SLE). Background: Belly dancer’s dyskinesia is a rare disease caused by…
- « Previous Page
- 1
- …
- 87
- 88
- 89
- 90
- 91
- …
- 132
- Next Page »